Clinical Trial Update: Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast Cancer

View source ↗

Summary

A clinical study using the PET imaging tracer 18F-FAPI-04 for breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 18F-FAPI-04 (Fluorine-18 labeled fibroblast activation protein inhibitor FAPI-04)

Snippet

Sponsor: The Affiliated Hospital of Qingdao University | Conditions: Breast Cancer | Status: RECRUITING